Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease

Alpha-synuclein is considered the major pathological protein associated with Parkinson’s disease, but there is still no effective immunotherapy which targets alpha-synuclein. In order to create a safer and more effective therapy against PD, we are targeting an epitope of alpha-synuclein rather than...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Ning, Song, Ge, Yang, Haiqiang, Lin, Xiaoyang, Brown, Breanna, Hong, Yuzhu, Cai, Jianfeng, Cao, Chuanhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539124/
https://www.ncbi.nlm.nih.gov/pubmed/31083520
http://dx.doi.org/10.3390/ijms20092338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539124/
https://www.ncbi.nlm.nih.gov/pubmed/31083520
http://dx.doi.org/10.3390/ijms20092338

Ejemplares similares